Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
Saito
Y
Y
Second Department of Internal Medicine, School of Medicine, Chiba University, Japan.
Shinomiya
M
M
Shirai
K
K
Yoshida
S
S
D000125:Achilles Tendon / Q000473:pathology; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001781:Blood Component Removal / Q000009:adverse effects / Q000379:methods*; D002784:Cholesterol / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000517:prevention & control; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000150:complications / Q000473:pathology / Q000628:therapy*; D007022:Hypotension / Q000209:etiology; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis / Q000009:adverse effects; D013997:Time Factors; D014973:Xanthomatosis / Q000473:pathology
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D008077:Lipoproteins, LDL; D002784:Cholesterol